FR3029105B1 - USE OF ESTERS OF ALPHA, OMEGA-ALKANEDIOLS AND AMINO ACID N-ACYL DERIVATIVES AS AN ANTI-AGING AGENT FOR HUMAN SKIN - Google Patents

USE OF ESTERS OF ALPHA, OMEGA-ALKANEDIOLS AND AMINO ACID N-ACYL DERIVATIVES AS AN ANTI-AGING AGENT FOR HUMAN SKIN Download PDF

Info

Publication number
FR3029105B1
FR3029105B1 FR1461584A FR1461584A FR3029105B1 FR 3029105 B1 FR3029105 B1 FR 3029105B1 FR 1461584 A FR1461584 A FR 1461584A FR 1461584 A FR1461584 A FR 1461584A FR 3029105 B1 FR3029105 B1 FR 3029105B1
Authority
FR
France
Prior art keywords
alkanediols
omega
alpha
esters
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1461584A
Other languages
French (fr)
Other versions
FR3029105A1 (en
Inventor
Laetitia Cattuzzato
Sandy Dumont
Jerome Guilbot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority to FR1461584A priority Critical patent/FR3029105B1/en
Publication of FR3029105A1 publication Critical patent/FR3029105A1/en
Application granted granted Critical
Publication of FR3029105B1 publication Critical patent/FR3029105B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
FR1461584A 2014-11-27 2014-11-27 USE OF ESTERS OF ALPHA, OMEGA-ALKANEDIOLS AND AMINO ACID N-ACYL DERIVATIVES AS AN ANTI-AGING AGENT FOR HUMAN SKIN Active FR3029105B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1461584A FR3029105B1 (en) 2014-11-27 2014-11-27 USE OF ESTERS OF ALPHA, OMEGA-ALKANEDIOLS AND AMINO ACID N-ACYL DERIVATIVES AS AN ANTI-AGING AGENT FOR HUMAN SKIN

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1461584 2014-11-27
FR1461584A FR3029105B1 (en) 2014-11-27 2014-11-27 USE OF ESTERS OF ALPHA, OMEGA-ALKANEDIOLS AND AMINO ACID N-ACYL DERIVATIVES AS AN ANTI-AGING AGENT FOR HUMAN SKIN

Publications (2)

Publication Number Publication Date
FR3029105A1 FR3029105A1 (en) 2016-06-03
FR3029105B1 true FR3029105B1 (en) 2018-01-26

Family

ID=52589539

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1461584A Active FR3029105B1 (en) 2014-11-27 2014-11-27 USE OF ESTERS OF ALPHA, OMEGA-ALKANEDIOLS AND AMINO ACID N-ACYL DERIVATIVES AS AN ANTI-AGING AGENT FOR HUMAN SKIN

Country Status (1)

Country Link
FR (1) FR3029105B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2977252B1 (en) * 2011-06-30 2013-08-02 Seppic Sa NOVEL ESTERS OF N-ACYLATED AMINO ACID DERIVATIVES AND ISOSORBID, PROCESS FOR THEIR PREPARATION, AND USE IN COSMETICS AND AS MEDICAMENT
FR2981932B1 (en) * 2011-10-27 2014-10-31 Seppic Sa NOVEL ESTERS OF N-ACYL DERIVATIVES OF AMINO ACIDS AND DIOLS, PROCESS FOR THEIR PREPARATION, AND USE IN COSMETICS AND AS A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
FR3029105A1 (en) 2016-06-03

Similar Documents

Publication Publication Date Title
IL277146A (en) Amino acid compounds and methods of use
MA41999A (en) OBETICHOLIC ACID COMPOSITIONS AND METHODS OF USE
DK3680329T3 (en) MODIFIED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T-CELL RECEPTOR ALPHA CONSTANT REGION
MA41031A (en) CYSTEAMINE-FATTY ACID CONJUGATES AND THEIR USE AS AUTOPHAGIC ACTIVATORS
CL2016002072A1 (en) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
SI3424920T1 (en) Co-crystals of (s)-n-methyl-8-(1-((2'-methyl-(4,5'-bipyrimidin)-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof as dna-pk inhibitors
EP3182886A4 (en) System and method for noninvasive analysis of tissue
IL282026A (en) Amino acid compounds and methods of use
EP3319510A4 (en) Tissue ablation and assessment system and method of use thereof
FR2997013B1 (en) METHOD AND APPARATUS FOR MASSAGE OF THE SKIN BY SUCTION AND PALPER-ROLL
FR3027518B1 (en) USE OF ISOSORBIDE ESTER AND N-ACYL DERIVATIVES OF AMINO ACIDS AS AN ANTI-AGING AGENT FOR HUMAN SKIN
EP3432778C0 (en) An apparatus and method to locate, measure and monitor inflammation of the skin's soft tissue
EP3243048A4 (en) Method and system for detection of surgical gauze during anatomical surgery
FR2992173B1 (en) COSMETIC HEALING PROCESS FOR SKIN AND / OR LIP
EP3134079A4 (en) Substituted n-(2-(amino)-2-oxoethyl)benzamide inhibitors of autotaxin and their preparation and use in the treatment of lpa-dependent or lpa-mediated diseases
ZA201801300B (en) Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections
DK2836203T3 (en) VESICULAR FORMULATION FOR USE IN THE TREATMENT OF PAIN OR REDUCED MOBILITY IN ONE JOINT
MA43730A (en) MALASSEZINE AND RELATED ANALOGUES AS SKIN LIGHTENING AGENTS
IL273922A (en) D-amino acid oxidase inhibitors and therapeutic uses thereof
FR3070494B1 (en) DIAGNOSTIC METHOD FOR SKIN SHOWING SIGNS OF AGING
UY33663A (en) AMINIC DERIVATIVES FOR THE TREATMENT OF SKIN PROLIFERATIVE DISORDERS
MA41377A (en) LEVODOPA AND CARBIDONA INTESTINAL GEL AND PROCEDURES FOR USE
BR112015006272A2 (en) '' cosmetic use, compounding, cosmetic composition and method of cosmetic treatment ''
IL261646A (en) Urea and amide derivatives and their use as cyclophilin inhibitors
FR3030253B1 (en) COMPOSITION FOR IMPROVING THE CELLULAR ASPECT OF THE SKIN

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160603

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10